Genetic Clues for Skin Cancer Therapies Yonkers NY

Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.

Local Companies

Francis Xavier Di Spaltro
(212) 838-0270
445 East 58th Street
New York, NY
Eyal Levit
(718) 376-1004
1220 Avenue P
Brooklyn, NY
Stanley Minkowitz
(718) 438-4948
941 48Th St
Brooklyn, NY
Jason Applebaum
(718) 357-8200
5847 188Th St
Flushing, NY
Julio Manrique
(718) 639-8788
3718 79Th St # 1
Flushing, NY
Ellis Gottesfeld
(212) 721-4614
185 West End Avenue Suite 1D
New York, NY
Mark Marciano
(212) 879-6522
1016 5Th Ave
New York, NY
Amy Batterman
(718) 377-3740
3131 Kings Hwy # D7
Brooklyn, NY
Cesar De Castro
(718) 261-0071
7716 Austin St # 2K
Flushing, NY
Richard Moskowitz
(516) 741-1730
173 Mineola Blvd # 203
Mineola, NY
Data Provided by:
  

Provided By:

MONDAY, Aug. 31 (HealthDay News) -- Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations.

Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma. Their study is published in the September issue of the journal Nature Genetics.

"We have found what appears to be an Achilles' heel of a sizable share of melanomas," Samuels, an investigator in the cancer genetics branch of the institute's Division of Intramural Research, said in a NIH news release.

The PTK family includes many genes that, when mutated, promote many types of cancer, including brain, gastric and lung malignancies, according to background information provided in the news release. In the new NIH study, one PTK gene that appeared particularly suspicious was the ERBB4 gene. Scientists found ERBB4 mutations in 19 percent of patients' tumors, making it the most frequently mutated PTK gene in melanoma. Additional lab studies found that melanoma cells with the ERBB4 defect were dependent on the mutant gene for their growth.

The researchers also found that two additional PTK genes -- FLT1 and PTK2B -- were mutated in about 10 percent of the tumor samples.

The discoveries could open up new avenues for therapies. For example, the researchers discovered that melanoma cells grew much more slowly when exposed to lapatinib (Tykerb), a chemotherapy drug that inhibits ERBB4. Lapatinib is already in use by some breast cancer patients. The NIH team is planning a clinical trial using lapatinib in patients with metastatic melanoma harboring ERBB4 mutations.

"Though additional work is needed to gain a more complete understanding of these genetic mutations and their roles in cancer biology, our findings open the door to pursuing specific therapies that may prove useful for the treatment of melanoma with ERBB4 mutations," Samuels stated.

More information

The American Cancer Society has more on melanoma.

SOURCE: U.S. National Institutes of Health, news release, Aug. 30, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Healing Facial Spider Veins Yonkers NY
Aging, genetics, hormones, over exposure to the sun, smoking, skin care therapies and other lifestyle options can break down your skin and let's don't forget facial spider veins. But the good news is that there are treatment options available to improve the skin's appearance and to heal spider veins in face.
- Filling in Wrinkles with Dermal Fillers Yonkers NY
- High Levels of Selenium Decreases Incidence of Skin Cancer. Yonkers NY
- Follow Up After Skin Cancer Yonkers NY
- Delayed Prostate Cancer Therapy Yonkers NY
- Gene Mutation in Dogs Yonkers NY
- Risk Factors for Squamous Cell Cancer of the Skin Yonkers NY
- Breast Cancer Treatment Yonkers NY
- Getting a Botox Cosmetic Injection Yonkers NY
- Risks for Childhood Cancer Survivors Yonkers NY